Company Filing History:
Years Active: 1991
Title: Simon H Stam: Innovator in Hypocholesterolemic Steroid Derivatives
Introduction
Simon H Stam is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid derivatives that serve as hypocholesterolemics. With a total of 2 patents to his name, Stam's work has the potential to impact cholesterol management and cardiovascular health.
Latest Patents
Stam's latest patents focus on steroid derivatives that are useful in lowering cholesterol levels. These patents detail lanosterols substituted in the 14 and/or 15 positions, which are effective in inhibiting lanosta-8,24-dien-3.beta.-ol 14.alpha.-methyl-demethylase activity. Additionally, they suppress 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity, thereby decreasing cholesterol synthesis and reducing serum cholesterol levels.
Career Highlights
Simon H Stam is currently associated with E.I. du Pont de Nemours and Company, a leading organization in the field of science and technology. His work at this company has allowed him to focus on innovative solutions for health-related challenges, particularly in cholesterol management.
Collaborations
Stam has collaborated with several esteemed colleagues, including James L Gaylor and Paul R Johnson. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.
Conclusion
In summary, Simon H Stam is a distinguished inventor whose work in hypocholesterolemic steroid derivatives has the potential to make a significant impact on health and wellness. His contributions to the field are noteworthy and reflect his commitment to innovation in pharmaceutical science.